New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 25, 2014
09:24 EDTNLST, IPHINetlist announces PTAB of USPTO denied Inphi request for rehearing
Netlist (NLST) announced that the Patent Trial and Appeal Board, or PTAB, of the United States Patent and Trademark Office, or USPTO, issued a final decision in the reexamination of U.S. Pat. No. 7,532,537 denying Inphi Corporation's request for a rehearing. The '537 reexamination appeal in the USPTO is now closed. With this action, the PTAB reaffirmed its earlier decision upholding the validity of all 60 claims in the '537 patent reexamination, dismissing every single validity challenge raised by Inphi. These claims are directed to fundamental concepts of load reduction and rank multiplication which are integral to the design of LRDIMMs at DDR3 and DDR4. Inphi's only opportunity to challenge the PTAB's final decision is an appeal to the U.S. Court of Appeals for the Federal Circuit, which it must file by mid-October. The '537 Patent is also the subject of litigation between Netlist and Inphi in the Central District of California, which has been stayed pending the outcome of the reexamination, including any subsequent appeals.
News For NLST;IPHI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 27, 2015
08:04 EDTNLSTNetlist reports Q4 EPS (14c), one estimate (12c)
Subscribe for More Information
March 26, 2015
07:15 EDTNLSTNetlist comments on jury verdict from Northern District Court of California
Subscribe for More Information
March 25, 2015
14:07 EDTNLSTNetlist drops 52% to 64c
Subscribe for More Information
March 18, 2015
07:29 EDTIPHINorthland Capital Markets to hold a conference
Subscribe for More Information
07:08 EDTIPHIInphi weakness creates buying opportunity, says Stifel
Subscribe for More Information
March 17, 2015
08:07 EDTNLSTNetlist announces positive ruling in patent battles in ULLtraDIMM case
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use